A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis
Clinical trial NCT07672561 · RECRUITING
Trial details
- NCT number
- NCT07672561
- Sponsor
- Zhejiang Wenda Pharma Technology LTD.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2026-11-30
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.